BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
MOLECULAR TARGETUniProt: Q9H422

HIPK3

homeodomain interacting protein kinase 3

28 compounds · BiohacksAI corpus v20260307-01

28
compounds
Compounds
28
Gene Symbol
HIPK3
NCBI Gene
10114

Looking for compounds that interact with HIPK3?

View all 28 compounds →
About HIPK3

HIPK3 (homeodomain interacting protein kinase 3) is a biological target studied in biomedical research. The BiohacksAI corpus identifies 28 compounds with documented interactions with this target, based on BindingDB assay data and PubMed literature.

View HIPK3 on UniProt →
Compounds Targeting HIPK3 (28)
1
Alvocidib
4.52
confidence
2
Foretinib
4.34
confidence
3
Ruxolitinib
4.23
confidence
4
Pi 103
4.17
confidence
5
Bosutinib
4.08
confidence
6
Bi 2536
4.01
confidence
7
Quizartinib
3.99
confidence
8
Midostaurin
3.85
confidence
9
Silmitasertib
3.78
confidence
10
Nintedanib
3.61
confidence
11
Bms 387032
3.47
confidence
12
Tae 684
3.43
confidence
13
Fedratinib
3.40
confidence
14
Linifanib
3.33
confidence
15
Dovitinib
3.09
confidence
16
Lestaurtinib
3.04
confidence
17
Ruboxistaurin
2.94
confidence
18
Defosbarasertib
2.89
confidence
19
R 406
2.83
confidence
20
Pha 665752
2.71
confidence
21
Plx 4720
2.71
confidence
22
Kw 2449
2.64
confidence
23
Gsk 690693
2.64
confidence
24
Ast 487
2.56
confidence
25
Su 014813
2.20
confidence
26
Sel 120 Free Base
1.95
confidence
300
studies
1.61
confidence
28
Pictilisibdrugage
0
studies
0.69
confidence
Top 28 compounds by confidence score. Derived from BindingDB assay data.
Data Source
Corpusv20260307-01
SourceBindingDB · ChEMBL · PubMed

All data is computationally derived from published research. Not medical advice. Independent validation required.